ArielDx® Pancreatitis
Clinical Decision Support

Comprehensive Next-Generation Sequencing (NGS) Genetic Risk Assessment For Pancreatitis and CFTR Related Disorders

ArielDx® Pancreatitis
& Add-on Panel ArielDx® Lipids

Targeted gene panel for early assessment of risk related to susceptibility to pancreatitis and related conditions

Most patients with a complex, chronic disorder don’t have a single cause for their disease. In fact, there are over 50 possible contributing factors related to pancreatitis that may combine to increase risk of future progression [1]. Each patient has a unique combination of genetic and accumulated environmental risk factors that should be evaluated before reaching chronic stage, an irreversible and expensive condition to manage.

Ariel recognizes the challenges of caring for patients with complex chronic disease. To support your management of these patients, Ariel has developed a comprehensive approach to genetic testing that goes beyond Mendelian disorders. Our integrated genetic panel and curated clinical summary is designed specifically for providers to identify and diagnose the underlying causes of symptoms to support clinical management.

ArielDx® Pancreatitis

ArielDx® Pancreatitis is a comprehensive next-generation sequencing panel of genes related to susceptibility to pancreatitis and related complications. ArielDx Pancreatitis tests for predisposition to both Mendelian (monogenic) and complex (multifactorial) forms of disease. A minority of pancreatitis patients have a monogenic cause of disease. Therefore, testing for predisposing risk variants in addition to monogenic disease variants assures a complete picture of known genetic predisposition. ArielDx Pancreatitis may be appropriate for anyone who has had unexplained attacks of acute pancreatitis, especially if they are under the age of 35, exhibit symptoms of pancreatic disease, such as abdominal pain after eating, chronic diarrhea, abnormal findings on a CT or MRI, or have an abnormal laboratory test linked to the pancreas.

Genes Included in Panel

CASR, CEL, CFTR, CLDN2, CPA1, CTRC, GGT1, PRSS1-2, PRSS3, SBDS, SLC26A9, SPINK1 and UBR1.

ArielDx® Lipids

ArielDx® Lipids is a next-generation sequencing panel for genes associated with abnormal lipid metabolism. Abnormal lipid metabolism can increase an individual’s risk for developing cardiovascular disease, fatty liver disease, and pancreatitis. It is an established cause of pancreatitis, accounting for up to 10% of acute pancreatitis cases [2]. Variants in several genes can cause hereditary disorders of lipid metabolism or increase an individual’s risk for elevated triglycerides, a type of fat (lipid), in the blood. Genetic testing may be helpful in determining the underlying cause of a patient’s disease and provide clinical guidance for targeted treatment. ArielDx Lipids may be appropriate for individuals with a personal or familial history of abnormal lipid metabolism and pancreatitis. It is available as an add-on to PancreasDx during the ordering process.

Genes Included in Panel

APOA5, APOC2, FABP4, LPL, PPARG,  and a region of interest in APOB exon 29.


Get Started With Your First Order

A New Approach to Complex Disease Care

At Ariel, we believe every patient is unique, therefore every patient’s disease management plan should be too.

That’s why we launched ADVANCE®, a new advanced genetics platform designed specifically for providers to identify and diagnose the underlying biological causes of symptoms and move beyond treating general symptoms.

The ADVANCE Precision Medicine Platform is a clinical decision support platform that simplifies diagnosis and informs more accurate treatment selection at the earliest signs of pancreatic diseases. ADVANCE integrates each individual’s genetics, environment, and family and medical history to provide clinicians more actionable insights into complex diseases, including evidence-based recommendations for management and treatment options.


Our AI powered technology combines deep sequencing genetics with advanced analytics and evidence-based knowledge to provide genetic testing and a report that is actionable and easy to use. Now, care teams can prevent or mitigate the most severe outcomes of complex chronic conditions using a comprehensive understanding of disease drivers and long-term prognoses.

In addition to traditional Mendelian variants, Ariel reports disease modifying and complex genetic variants.

Advanced Genetics

In addition to traditional Mendelian variants, Ariel reports disease modifying and complex genetic variants.

Patient Specific

Our reports are tailored to each patient, integrating patient reported outcomes, environmental and medical history into the interpretation of the genetic data.

Expertise

Expertise

Our expert system provides you with clinical considerations according to guidelines and continuously updates you and your patients if variants are reclassified.

Quality

Our platform uses some of the highest quality next-generation sequencing on the market and our laboratory is CLIA-certified. 

How It Works

Ariel Precision Medicine ADVANCE cloud-based clinical decision support platform
Play Video

How Ariel Benefits Providers

icon-view-results

Unravel Complex Conditions

Our platform integrates a patient’s symptoms and genetics with complex medical information.

icon-comprehensive-team

Available Genetic Counseling

Pre- and/or post-test genetic counseling if you need extra help with genetic testing.

Ariel expertise
icon-pancreatitis

Comprehensive Genetic Testing

Analyzes multiple risk factors that are disease causing rather than just assessing single gene risk factors.

icon-create-account

Secure Online Test Management

Order and review test results, add medical team and request patient consent using our portal.

ArielDx® Pancreatitis Brochure

How Genetic Testing
Optimizes Clinical Management

There is growing evidence that suggests that most diseases of the pancreas have a genetic predisposition or basis. Genetic testing can help provide advanced insights to help you create a comprehensive and more personalized clinical management plan for your patient.

As an MD, I am frustrated with the lack of effective treatment for pancreatic diseases. As a PhD, I am excited about new breakthroughs in knowledge and possibilities for the future. As a member of the Ariel Team, I am thrilled to see science meet medicine to provide those future solutions – NOW!

David Whitcomb, MD, PhD

Co-Founder and Chairman, Ariel Precision Medicine

Frequently Asked Questions

Frequently asked questions about ArielDx Pancreatitis , ArielDx Lipids, Ariel Precision Medicine, and how you can use genetic information to improve outcomes for your patients.

Identifying the underlying biological causes of symptoms can help direct therapy and guide medical management specific to the patient’s disease process. For example, genetic conditions such as hereditary pancreatitis and cystic fibrosis can both increase the risk of pancreatitis, but involve different treatments and clinical considerations. Early detection of the cause or causes of the disease process may prevent extensive diagnostic evaluations, delayed diagnosis and more severe end-stage disease.

Genetic testing for pancreatitis is recommended for individuals with pancreatitis that meet one or more of the following criteria:

  • An unexplained episode of acute pancreatitis in childhood
  • Recurrent acute or chronic pancreatitis without a known cause, particularly with early-onset
  • A family history of pancreatitis of unknown cause
  • A family history of pancreatitis with an established genetic cause
  • Additional symptoms consistent with a genetic disorder that includes pancreatitis as a symptom, such as cystic fibrosis or a CFTR-related disorder

Additionally, individuals that meet any of the following criteria may also benefit from genetic testing:

  • One or more attacks (or suspected attacks) of acute pancreatitis
  • Abdominal pain after eating, chronic diarrhea, abnormal findings on a CT or MRI scan, or an abnormal laboratory test related to the pancreas
Ariel’s test goes beyond genetics to incorporate genetic testing, patient medical and family history, patient biomarkers, and up-to-date management considerations to provide a comprehensive and actionable precision medicine report. ArielDx Pancreatitis tests for predisposition to both Mendelian (monogenic) and complex (multifactorial) forms of disease. A minority of pancreatitis patients have a monogenic cause of disease. Therefore, testing for predisposing risk variants in addition to monogenic disease variants assures a complete picture of known genetic predisposition.
ArielDx® Pancreatitis is a comprehensive next-generation sequencing panel of genes related to susceptibility to pancreatitis and related complications. ArielDx® Lipids is a next-generation sequencing panel of genes associated with abnormal lipid metabolism that may increase risk of pancreatitis. ArielDx® Lipids is available as an add-on to ArielDx® Pancreatitis during the ordering process.
Ariel is committed to a streamlined and convenient ordering and results disclosure process:
  1. ArielDx® Pancreatitis is a clinician-ordered test. To begin, create an account through the easy-to-use and secure Ariel online provider portal to place the order.
  2. Once the order is placed, your patient will receive an email from Ariel inviting them to register online, sign test consent forms, access help resources, and complete their health profiles.
  3. A buccal swab kit will be mailed to your patient’s home. The patient will be provided with instructions to swab the inside of their cheek and return their DNA sample by mail.
  4. Upon receipt of the DNA sample, completion of genetic testing and subsequent expert review of the findings, your patient’s test results will be released electronically through the secure Ariel portal. Clinicians and staff have a centralized area for managing different patient orders, requesting genetic counseling, and electronic release of results to patients.

The process for adding an ArielDx Lipids order to an existing or completed order is:

  1. Log into your Ariel account.
  2. Select the appropriate patient from you dashboard or Patient tab.
  3. Once you are in the patient’s profile, select “Request Additional Analysis” on the right.
  4. Check the box next to ArielDx Lipids and select “continue”.
  5. Authorize the order by checking the box and providing your signature. If you are submitting an order on behalf of an authorizing physician, his or her signature will be required before it can be processed.
    The authorizing provider will receive an email notification letting them know to complete this step.
  6. Results will be released electronically to your Ariel account.
Ariel accepts all insurance plans. As a new provider, we are not considered an in-network provider with all insurance plans. While the organization continues to grow, Ariel will work towards establishing in-network status. The Ariel team follows the process below:
  1. When a physician orders ArielDx Pancreatitis the patient will receive a ‘Welcome’ email with a link to Ariel’s secure patient portal to register. During registration, they will be asked to provide their insurance information.
  2. The Ariel team will contact the patient’s insurance to verify eligibility and benefits to assess potential costs for the patient. It is important to note that initial determinations from the patient’s insurance are subject to change, based on the patient’s clinical record and the discretion of the insurer.
  3. Ariel’s billing team will contact the patient by phone to discuss benefits findings and the patient’s potential financial responsibility (i.e. co-pay, co-insurance, deductible). Ariel works with the patient’s insurance directly through the claims and appeals process. Our team will exhaust all efforts to obtain payment from the patient’s insurance plan to reduce or eliminate patient responsibility for the service. During the billing process, Ariel may ask the ordering provider to supply additional documentation to support the medical necessity of the service for your patient.
For add-on panels, Ariel offers a direct patient-pay price of $100 (per test) * to make testing more accessible for patients. Patients can choose to go through their insurance. However, the patient should be made aware that most insurance plans do not cover add-on tests, like ArielDx Lipids, and may result in out-of-pocket costs up to $1000. Patients will be prompted to select their payment method during the registration process.

Please note: Add-on testing cannot be completed until payment has been resolved.

*The patient-pay price cannot be offered after a claim has been submitted to the insurance.
Patients that select the direct pay option will pay the full $100 upfront. Ariel accepts checks and all major credit cards. Payments can be made through the Ariel Patient Portal, by phone at 844-692-7435 or by mail.

Checks should be made payable to: Ariel Precision Medicine

Mailing Address:

Ariel Precision Medicine
Attn: Accounts Receivable
5750 Centre Ave,
Suite 270
Pittsburgh, PA 15206
Ariel upholds the highest security measures to help ensure any personal information remains safe. We do not store cardholder data (“CHD”) in any cases.

Ariel is required by law to bill patients for applicable co-pays, co-insurance, and deductibles, as directed by their individual insurance benefit plan. Ariel will partner with the patient to implement the most appropriate payback plan based on the individual’s financial need.

Depending on the patient’s insurance plan, there may be situations where Ariel is considered an out-of-network provider and the payment for our test will be sent to the patient directly. The patient is legally responsible for re-issuing that payment, with a copy of the Explanation of Benefits, to Ariel for processing.

To ensure that ArielDx Pancreatitis is accessible to medically necessary patients, several options are available to support any patient out-of-pocket costs remaining after all billing efforts are exhausted with the insurance plan. Available options include payment plans, prompt pay discounts, and financial assistance, based on individual need. The direct-pay option for ArielDx Lipids does not allow Ariel to submit claims to insurance providers or apply patient assistance programs—this is how we are able to keep the patient-pay price so low.
Yes. Ariel offers genetic counseling services for patients through an independent third-party genetic counseling provider over video or phone. Pre-test genetic counseling through a third-party is complimentary with every test, which clinicians can request with every order. A request for post-test genetic counseling can be made through the Ariel provider portal. At that time, the patient’s contact information and  ArielDx Pancreatitis test results are provided to a third-party genetic counseling service. This third party service will contact the patient to discuss cost and scheduling.
Ariel offers educational materials on pancreatitis, genetic testing, complex disease and other pertinent topics for clinicians and patients inside the portal. Patient counseling materials for use during informed consent discussions and test ordering are available. Ariel also offers genetic counseling services for patients through an independent third-party genetic counseling provider over video or phone. Pre-test genetic counseling through a third party is included as an option with every test, which clinicians can request with every order. A request for post-test genetic counseling can be made through the Ariel provider portal. At that time, the patient’s contact information and ArielDx Pancreatitis test results are provided to a third-party genetic counseling service. This third-party service will contact the patient to discuss cost and scheduling.

Please tell your patient to expect an email from Ariel. Once you place an order in the secure portal, Ariel will send your patient a ‘Welcome’ email with a link to Ariel’s secure patient portal to register. The patient can then follow the instructions in their email to register in Ariel’s online portal, provide their insurance information and complete the informed consents and their patient profile. Once the requisite forms are compete, Ariel dispatches a DNA testing kit to the patient’s house. This kit also has all the necessary instructions for collecting the sample and shipping it back to Ariel.

Ariel will be able to use sequence data from the previously collected samples. In instances in which the analysis is not possible, Ariel will send a new collection kit to the patient.
For new patient orders, the turnaround time for the test is approximately 4 to 6 weeks from the time the patient sample is received in our laboratory. For patients that have previously had ArielDx Pancreatitis testing, the turnaround time for add-on panel results is 2-3 weeks from the time Ariel receives the additional order.
Don’t hesitate to reach out to Ariel’s Customer Service department, Monday through Friday, 8 a.m. – 8 p.m. EST at (844) 692-7435 or via info@arielmedicine.com.

Still Have Questions?

If you still have questions, we would love to answer them. Request a quick call with our team and we’ll be in touch.